Aspirin and warfarin are both effective in reducing ischemic stroke and systemic embolism in patients with atrial fibrillation.

3 dec 2017 · The 1991 Stroke Prevention in Atrial Fibrillation (SPAF) study evaluated the comparative efficacy of warfarin, aspirin, and placebo for stroke ...

SPAF Webinars, both accredited and non-accredited, examine timely topics surrounding optimal stroke prophylaxis strategies for the management of AF related ...

Patients with AF who have relatively low rates of ischemic stroke, particularly disabling stroke, during treatment with aspirin can be reliably identified.

These three barriers make up what we call the “Security & Privacy Acceptance Framework”. (SPAF). We then review and critically analyze prior work that has ...

Gallery · Packages · About · Menu

Aspirin and warfarin are both effective in reducing ischemic stroke and systemic embolism in patients with atrial fibrillation. Because warfarin-eligible ...

ischemic strokes, TIAs, and systemic emboli in this double-blinded portion of the SPAF Study, risk reduction was 44% (p<0.01; 95% confidence inter- val, 17-62%) ...

SPAF 2023 explored fundamental concepts and advancements in LAA closure and oral anticoagulation therapy, along with adjunctive and alternative strategies for ...

22 nov 2021 · Atrial fibrillation is the most common heart arrhythmia. Inappropriate contractile signals from the atria lead to rapid ventricular rate ...